Krishnan Suma 的 Form 4 申報
Krystal Biotech, Inc.（KRYS），2023/1/19 申報
- 申報編號
- 0001298711-23-000006
- 申報時間
- 2023/1/19
- 交易日
- 2023/1/17-1/18
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 10 筆非衍生性交易。公開市場賣出合計 $404.0 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Krishnan SumaCIK 0001298711 | 董事、高階主管（President, R&D）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/1/17 | Common Stock | S賣出處分 | −20,617 | $80.70F2 | −$1,663,791.9 | 1,681,646 | 直接 | 重複申報 |
| 2023/1/17 | Common Stock | S賣出處分 | −1,186 | $81.41F3 | −$96,552.26 | 1,680,460 | 直接 | 重複申報 |
| 2023/1/17 | Common Stock | S賣出處分 | −345 | $82.72F4 | −$28,538.4 | 1,680,115 | 直接 | 重複申報 |
| 2023/1/17 | Common Stock | S賣出處分 | −20,617 | $80.70F2 | −$1,663,791.9 | 1,743,071 | 間接 | 重複申報 |
| 2023/1/17 | Common Stock | S賣出處分 | −1,186 | $81.41F3 | −$96,552.26 | 1,741,885 | 間接 | 重複申報 |
| 2023/1/17 | Common Stock | S賣出處分 | −346 | $82.71F4 | −$28,617.66 | 1,741,539 | 間接 | 重複申報 |
| 2023/1/18 | Common Stock | S賣出處分 | −2,048 | $80.75F8 | −$165,376 | 1,678,067 | 直接 | 重複申報 |
| 2023/1/18 | Common Stock | S賣出處分 | −804 | $81.56F9 | −$65,574.24 | 1,677,263 | 直接 | 重複申報 |
| 2023/1/18 | Common Stock | S賣出處分 | −2,048 | $80.75F8 | −$165,376 | 1,739,491 | 間接 | 重複申報 |
| 2023/1/18 | Common Stock | S賣出處分 | −803 | $81.56F9 | −$65,492.68 | 1,738,688 | 間接 | 重複申報 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The transaction was executed in multiple trades ranging from $80.1300 to $81.1000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。
- F3
The transaction was executed in multiple trades ranging from $81.1300 to $82.0600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。
- F4
The transaction was executed in multiple trades ranging from $82.3300 to $83.2500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。
- F8
The transaction was executed in multiple trades ranging from $80.3500 to $81.3300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。
- F9
The transaction was executed in multiple trades ranging from $81.3700 to $81.9200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。